跳至主要内容
临床试验/NCT03058016
NCT03058016Unknown不适用

Personalized Nutrition Prediction for Metabolic Syndrome Patients, an Open Single-center Study

Galilee CBR0 个研究点目标入组 500 人开始时间: 2017年4月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
500
主要终点
To determine number of participants with reduced BMI

研究概览

简要总结

This clinical study is designed to evaluate the providing of a computational prediction engine for optimization of personalized nutrition

Personalized recommendations for effective diet, lifestyle and activities based on the patient's parameters measurements and reactions will be provided on a bi-weekly basis, all Lab tests and dietician control will be performed twice a month.

详细描述

Pre-diabetic and pre-metabolic syndrome patients will be recruited to the study for a period of one year.

After measurement of individual's parameters changes as blood tests, gut microbiome, urine tests, blood pressure, heart performance, body circumferences, mood and mental status as well as monitoring each individual's food intake - a model to predict individual's body reaction according to lifestyle, eating and activity habits will be built.

Personalized recommendations for effective diet, lifestyle and activities based on the patient's parameters measurements and reactions will be provided on a bi-weekly basis, all Lab tests and dietician control will be performed twice a month.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults age 18-65
  • HBA1C between 5.5 and 7%.
  • Altered lipid metabolism
  • Signed Informed Consent

排除标准

  • Usage of antibiotics within three months prior to participation
  • Chronically active inflammatory or neoplastic disease in the three years prior to enrollment
  • Chronic gastrointestinal disorder, including Inflammatory Bowel Disease and Celiac Disease
  • Skin disease, including contact dermatitis, precluding proper attachment of the continuous glucose monitor
  • Active psychiatric disorder
  • Myocardial infarction or cerebrovascular accident in the 6 months prior to participation
  • Chronic immunosuppressive medication usage
  • Clinical depression

结局指标

主要结局

To determine number of participants with reduced BMI

时间窗: One year

Change at 12 months

To determine number of participants with reduced hA1C

时间窗: One year

Change at 12 months

To determine number of participants with reduced cholesterol

时间窗: One year

Change at 12 months

次要结局

  • Type of intestinal microorganisms(One year)
  • Number of intestinal microorganisms(One year)

研究者

发起方
Galilee CBR
申办方类型
Industry
责任方
Sponsor

相似试验